rs1247392012

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 6P and 1B. PM2PM5PP5_ModerateBP4

The NM_145868.2(ANXA11):​c.119A>G​(p.Asp40Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000145 in 1,376,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D40Y) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000015 ( 0 hom. )

Consequence

ANXA11
NM_145868.2 missense

Scores

4
15

Clinical Significance

Pathogenic criteria provided, single submitter P:3

Conservation

PhyloP100: 4.81

Publications

30 publications found
Variant links:
Genes affected
ANXA11 (HGNC:535): (annexin A11) This gene encodes a member of the annexin family, a group of calcium-dependent phospholipid-binding proteins. Annexins have unique N-terminal domains and conserved C-terminal domains, which contain calcium-dependent phospholipid-binding sites. The encoded protein is a 56-kD antigen recognized by sera from patients with various autoimmune diseases. Several transcript variants encoding two different isoforms have been identified. [provided by RefSeq, Dec 2015]
ANXA11 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 23
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • inclusion body myopathy and brain white matter abnormalities
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr10-80170853-C-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 802593.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP5
Variant 10-80170852-T-C is Pathogenic according to our data. Variant chr10-80170852-T-C is described in ClinVar as Pathogenic. ClinVar VariationId is 488353.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.21516684). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANXA11NM_145868.2 linkc.119A>G p.Asp40Gly missense_variant Exon 4 of 16 ENST00000422982.8 NP_665875.1 P50995-1Q5T0G8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANXA11ENST00000422982.8 linkc.119A>G p.Asp40Gly missense_variant Exon 4 of 16 1 NM_145868.2 ENSP00000404412.2 P50995-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000114
AC:
2
AN:
174858
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000234
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000145
AC:
2
AN:
1376080
Hom.:
0
Cov.:
30
AF XY:
0.00000147
AC XY:
1
AN XY:
679800
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29908
American (AMR)
AF:
0.00
AC:
0
AN:
29362
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20828
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36876
South Asian (SAS)
AF:
0.00
AC:
0
AN:
71010
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50898
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5390
European-Non Finnish (NFE)
AF:
0.00000186
AC:
2
AN:
1075040
Other (OTH)
AF:
0.00
AC:
0
AN:
56768
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

ANXA11-related disorder Pathogenic:1
Jan 16, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The ANXA11 c.119A>G variant is predicted to result in the amino acid substitution p.Asp40Gly. This variant has been reported in individuals with amyotrophic lateral sclerosis (ALS) or ALS-frontotemporal dementia (ALS-FTD) (Smith et al. 2017. PubMed ID: 28469040; Zhang et al. 2018. PubMed ID: 29845112; Nahm et al. 2020. PubMed ID: 33087501; Wang et al. 2022. PubMed ID: 36226077). It was reported to segregate with disease in at least two families (Smith et al. 2017. PubMed ID: 28469040). Experimental studies are consistent with the p.Asp40Gly substitution impacting protein function (Smith et al. 2017. PubMed ID: 28469040; Nahm et al. 2020. PubMed ID: 33087501). This variant is reported in 0.0023% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -

not provided Pathogenic:1
Jan 12, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects ANXA11 function (PMID: 28469040, 33087501). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 488353). This missense change has been observed in individuals with amyotrophic lateral sclerosis (PMID: 28469040, 29845112, 33087501). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 40 of the ANXA11 protein (p.Asp40Gly). -

Amyotrophic lateral sclerosis type 23 Pathogenic:1
Jan 29, 2018
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Benign
-0.055
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0088
T;T;.;T;.
Eigen
Benign
0.13
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.74
.;.;T;T;T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.22
T;T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.2
L;L;.;L;.
PhyloP100
4.8
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-0.24
N;N;.;N;D
REVEL
Benign
0.18
Sift
Benign
0.55
T;T;.;T;D
Sift4G
Benign
0.51
T;T;T;T;T
Polyphen
0.97
D;D;.;D;.
Vest4
0.64
MutPred
0.30
Loss of stability (P = 0.0533);Loss of stability (P = 0.0533);.;Loss of stability (P = 0.0533);Loss of stability (P = 0.0533);
MVP
0.21
MPC
0.074
ClinPred
0.31
T
GERP RS
4.7
Varity_R
0.19
gMVP
0.35
Mutation Taster
=7/93
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1247392012; hg19: chr10-81930608; API